Core Scientific Forges AI Data Center Alliance with AMD
Money

Core Scientific Forges AI Data Center Alliance with AMD

authorBy Ramit Sethi
DateJul 28, 2026
Read Time3 min

Core Scientific, a company that has successfully pivoted from Bitcoin mining to AI data center operations, has recently announced a major partnership with chip manufacturer Advanced Micro Devices (AMD). This strategic collaboration aims to develop a cutting-edge artificial intelligence data center, marking a significant milestone for both entities. The agreement entails AMD securing a 15-year lease for 529 megawatts of AI capacity across Core Scientific's facilities in the U.S., a venture expected to yield more than $14 billion in revenue for Core Scientific. This move solidifies Core Scientific's position in the rapidly expanding AI infrastructure market, showcasing its adaptability and forward-thinking business strategy.

The alliance between Core Scientific and AMD is designed to cater to AMD's customer deployments, with operations slated to begin in 2027. This long-term engagement will see AMD utilize Core Scientific's data center infrastructure in Texas and Oklahoma to power its advanced AI computing needs. Beyond just leasing capacity, the two companies are set to engage in joint efforts to enhance data center design and optimize the integration of AMD's microchips, processors, and software. This partnership not only promises substantial financial returns for Core Scientific but also provides AMD with dedicated, high-capacity AI infrastructure to support its technological advancements.

Strategic Shift to AI Infrastructure

Core Scientific, once predominantly known for its Bitcoin mining activities, has strategically reoriented its business model towards the burgeoning field of artificial intelligence data centers. This pivotal shift is underscored by its recent partnership with Advanced Micro Devices (AMD), a leading chip manufacturer. The collaboration involves AMD committing to a 15-year lease of 529 megawatts of AI capacity from Core Scientific, a deal that is poised to generate an impressive revenue exceeding $14 billion for the data center operator. This transformation highlights Core Scientific's agility in adapting to market demands and its foresight in capitalizing on the growing need for robust AI infrastructure.

The transition from cryptocurrency mining to AI data services represents a significant diversification for Core Scientific. By leveraging its existing infrastructure and expertise, the company is now positioning itself at the forefront of AI development. This strategic redirection not only provides a stable and substantial revenue stream through long-term contracts with industry giants like AMD but also mitigates the volatility often associated with the cryptocurrency market. The 529-megawatt lease signifies a massive commitment from AMD, reflecting the critical role Core Scientific will play in supporting advanced AI computations, reinforcing its new identity as a key provider of AI data center solutions.

Advancing AI Capabilities Through Collaborative Innovation

The partnership between Core Scientific and AMD extends beyond a mere capacity lease, encompassing a comprehensive collaboration aimed at advancing AI capabilities. The agreement is structured to support AMD's customer deployments, with services anticipated to commence in 2027. AMD will utilize Core Scientific's state-of-the-art data centers located in Texas and Oklahoma, providing the necessary computing power for its diverse AI initiatives. This synergistic relationship is expected to drive innovation in data center design and optimize the deployment of AMD's cutting-edge microchips, processors, and software solutions.

This collaborative effort emphasizes the commitment of both companies to push the boundaries of artificial intelligence technology. By working together on data center design, Core Scientific and AMD aim to create highly efficient and scalable environments tailored for demanding AI workloads. Furthermore, the integration of AMD's advanced hardware and software within Core Scientific's infrastructure will facilitate faster processing and enhanced performance for AI applications. The deal also includes provisions for AMD to acquire up to 30 million Core Scientific shares, aligning the interests of both companies and fostering a deeper, mutually beneficial long-term partnership that promises to accelerate the development and deployment of next-generation AI technologies.

More Articles
Money
Cryptocurrency Markets Face Downturn Ahead of Federal Reserve Meeting
Bitcoin and Ethereum experienced significant price drops on Tuesday, July 28, 2026, as investors braced for the Federal Reserve's two-day meeting. Bitcoin opened 2.5% lower at $63,706.66, further declining to $63,327.39. Ethereum also fell 3.2% to $1,890.67, reaching $1,877.71. Market volatility is high due to potential interest rate hikes and global geopolitical developments, making the Fed's decision particularly impactful.
By Chika UwazieJul 28, 2026
Money
AstraZeneca's Pharmaceutical Pipeline: A Tale of Divergent Analyst Views
AstraZeneca's drug development pipeline is drawing contrasting opinions from financial analysts. Citibank has raised its price target for the company, citing solid second-quarter performance and a robust pipeline with numerous Phase III trials expected in 2027. Conversely, Deutsche Bank maintains a 'sell' rating, expressing a more cautious outlook. Despite a recent trial setback, AstraZeneca's CEO remains confident in achieving the company's ambitious revenue targets, backed by strong growth in oncology and rare disease sectors.
By Dave RamseyJul 28, 2026
Money
Leading Analyst Recommendations: Upgrades and Downgrades Across Key Sectors
This report compiles the most impactful Wall Street research calls, highlighting significant analyst upgrades and downgrades for various companies. Key upgrades include Intuitive Surgical, Edwards Lifesciences, Honeywell, Nutrien, and International Paper, driven by positive market shifts and strong company performance. Conversely, Intuit, Clorox, Albertsons, Levi Strauss, and RXO Inc. faced downgrades due to revised market outlooks and company-specific challenges. The article also covers initial coverage for several medical and financial firms.
By Scott PapeJul 28, 2026
Money
Liquidia Corporation: Significant Upside Predicted by Buckley Capital Advisors
Buckley Capital Advisors, in its Q2 2026 investor letter, highlighted Liquidia Corporation (NASDAQ:LQDA) as a key performer with over 50% potential upside. The firm anticipates a favorable ruling on Liquidia's Yutrepia product for PH-ILD, likely paving the way for a potential acquisition. Liquidia, a biopharmaceutical company focusing on cardiopulmonary diseases, has seen substantial share appreciation, driven by its promising therapeutic developments and strategic market position.
By Ramit SethiJul 28, 2026
Money
Boeing's Stellar Second Quarter: Exceeding Expectations and Boosting Cash Flow
Boeing announced its second-quarter earnings, surpassing revenue and cash flow projections, driven by increased jet deliveries. Despite a $280 million charge related to the new Air Force One program, the company achieved positive adjusted free cash flow, marking continued progress under CEO Kelly Ortberg's leadership. This performance indicates a robust recovery trajectory for the aerospace giant, with significant gains in commercial airplane revenue and promising developments in its defense sector.
By Natalie PaceJul 28, 2026